Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group (Q40944828)
scientific article published on January 1996
Language:
(P31) (Q13442814)
(P304) 54-60; discussion 80-4
(P407) (Q1860)
(P433) 1A Suppl
(P478) 47
(P577) Monday, January 1, 1996
(P921) (Q1988832)
(P1433) (Q7900884)
(P1476) "Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group" (language: en)
(P2093) Schellhammer P
Sharifi R
Block N
Soloway M
Venner P
Patterson AL
Sarosdy M
Vogelzang N
Jones J
Kolvenbag G
(P2860) (Q72396585)
(Q40895435)
(Q68177742)
(Q41261975)
(Q41185534)
(Q68426702)
(Q36768812)
(Q72636465)
(Q72636444)
(Q40760668)
(Q34444273)
(Q69781634)
(Q68426706)
(Q39520670)
other details
description scientific article published on January 1996

External Links